Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Penicillamine gastro-resistant 150mg tablets
1001030F0AAAMAM
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Penicillamine gastro-resistant 300mg tablets
1001030F0AAANAN
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Pennsaid 16mg/ml cutaneous solution
1003020U0BEAAAD
|
Pennsaid | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Pentane 40% / Levomenthol 2% spray
1003020Y0AAABAB
|
Freeze spray | Freeze sprays and gels | Musculoskeletal and Joint Diseases | No data available |
|
Phenylbutazone 200mg tablets
1001010Q0AAACAC
|
Phenylbutazone | Phenylbutazone | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 10mg dispersible tablets
1001010R0AAADAD
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 20mg dispersible tablets
1001010R0AAAEAE
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 20mg suppositories
1001010R0AAACAC
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam 20mg/1ml solution for injection ampoules
1001010R0AAAHAH
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Piroxicam betadex 20mg tablets
1001010R0AAAKAK
|
Piroxicam (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Pirozip 10 capsules
1001010R0BDAAAA
|
Pirozip | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Pirozip 20 capsules
1001010R0BDABAB
|
Pirozip | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Power Health Vegetarian Glucosamine hydrochloride 750mg tab
1001050A0BDAAAB
|
Power (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
PR Freeze spray
1003020Y0BBAAAA
|
PR Freeze | Freeze sprays and gels | Musculoskeletal and Joint Diseases | No data available |
|
PR Heat spray
1003020N0BNAAAU
|
PR Heat | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Prednisolone 25mg/1ml suspension for injection ampoules
1001022N0AAABAB
|
Prednisolone acetate (Systemic) | Prednisolone acetate | Musculoskeletal and Joint Diseases | No data available |
|
Premier Glucosamine hydrochloride 750mg caplets
1001050A0BJAAAB
|
Premier (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Prexige 100mg tablets
1001010ANBBAAAA
|
Prexige | Lumiracoxib | Musculoskeletal and Joint Diseases | No data available |
|
Prexige 400mg tablets
1001010ANBBABAB
|
Prexige | Lumiracoxib | Musculoskeletal and Joint Diseases | No data available |
|
Pro Coxam 1500mg tablets
1001050A0CCACAH
|
Pro Coxam | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Pro Coxam 500mg tablets
1001050A0CCAAAJ
|
Pro Coxam | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Pro Coxam 625mg tablets
1001050A0CCABAA
|
Pro Coxam | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Probenecid 250mg tablets
1001040K0AAADAD
|
Probenecid | Probenecid | Musculoskeletal and Joint Diseases | No data available |
|
Probenecid 300mg tablets
1001040K0AAAFAF
|
Probenecid | Probenecid | Musculoskeletal and Joint Diseases | No data available |
|
Proflex 5% cream
1003020P0BBAAAA
|
Proflex (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.